BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 19000643)

  • 1. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.
    Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R
    Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety.
    Havrylyuk D; Mosula L; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
    Eur J Med Chem; 2010 Nov; 45(11):5012-21. PubMed ID: 20810193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One pot synthesis of thiazolodihydropyrimidinones and evaluation of their anticancer activity.
    Holla BS; Rao BS; Sarojini BK; Akberali PM
    Eur J Med Chem; 2004 Sep; 39(9):777-83. PubMed ID: 15337290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
    Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
    Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
    Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity.
    Havrylyuk D; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
    J Med Chem; 2012 Oct; 55(20):8630-41. PubMed ID: 22992049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New 5-substituted thiazolo[3,2-b][1,2,4]triazol-6-ones: synthesis and anticancer evaluation.
    Lesyk R; Vladzimirska O; Holota S; Zaprutko L; Gzella A
    Eur J Med Chem; 2007 May; 42(5):641-8. PubMed ID: 17303290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
    Al-Saadi MS; Rostom SA; Faidallah HM
    Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
    Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
    Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazoline bearing benzimidazoles: search for anticancer agent.
    Shaharyar M; Abdullah MM; Bakht MA; Majeed J
    Eur J Med Chem; 2010 Jan; 45(1):114-9. PubMed ID: 19883957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents.
    Dawood KM; Eldebss TM; El-Zahabi HS; Yousef MH; Metz P
    Eur J Med Chem; 2013; 70():740-9. PubMed ID: 24231309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 2-substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl)phenyl]acetamide derivatives and evaluation of their anticancer activity.
    Ozkay Y; Işikdağ I; Incesu Z; Akalin G
    Eur J Med Chem; 2010 Aug; 45(8):3320-8. PubMed ID: 20451307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, crystal structure and biological evaluation of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives.
    Zheng LW; Zhu J; Zhao BX; Huang YH; Ding J; Miao JY
    Eur J Med Chem; 2010 Dec; 45(12):5792-9. PubMed ID: 20947221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel derivatives of methyl and ethyl 2-(4-oxo-8-aryl-2H-3,4,6,7-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetates from biologically active 1-aryl-2-hydrazinoimidazolines: synthesis, crystal structure and antiproliferative activity.
    Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
    Eur J Med Chem; 2006 Dec; 41(12):1373-84. PubMed ID: 16996655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, spectroscopy (IR, multinuclear NMR, ESI-MS), diffraction, density functional study and in vitro antiproliferative activity of pyrazole-beta-diketone dihalotin(IV) compounds on 5 melanoma cell lines.
    Pettinari C; Caruso F; Zaffaroni N; Villa R; Marchetti F; Pettinari R; Phillips C; Tanski J; Rossi M
    J Inorg Biochem; 2006 Jan; 100(1):58-69. PubMed ID: 16313961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
    Al-Saadi MS; Faidallah HM; Rostom SA
    Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted thiazoles VII. Synthesis and antitumor activity of certain 2-(substituted amino)-4-phenyl-1,3-thiazole analogs.
    Hassan GS; El-Messery SM; Al-Omary FA; El-Subbagh HI
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6318-23. PubMed ID: 22995621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
    Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
    Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity.
    Subtel'na I; Atamanyuk D; Szymańska E; Kieć-Kononowicz K; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
    Bioorg Med Chem; 2010 Jul; 18(14):5090-102. PubMed ID: 20594860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anticancer activity of isatin-based pyrazolines and thiazolidines conjugates.
    Havrylyuk D; Kovach N; Zimenkovsky B; Vasylenko O; Lesyk R
    Arch Pharm (Weinheim); 2011 Aug; 344(8):514-22. PubMed ID: 21681810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.